United States Virginia change
Sri Lanka Breaking News
Sri Lanka parliament
vivalankaSri Lanka newsSri Lanka businessSri Lanka sportsSri Lanka technologySri Lanka travelSri Lanka videosSri Lanka eventssinhala newstamil newsSri Lanka business directory
vivalanka advertising
Menu
Stay Connected
facebooktwittermobile
Popular Searches
T20 World Cup
Sponsored Links
Sri Lanka Explorer

Elder Health Care to enter Lankan market via Ceylon and Foreign Trades

Aug 29, 2011 3:08:36 PM - www.ft.lk

New Delhi :  Elder Health Care today said that it will enter the Sri Lankan market by next month with the launch of branded personal care products and is scouting for acquisitions in Europe as part of global expansion plans.
The Mumbai-based firm, which mainly sells in-licensed products, also plans to boost its own brands and will introduce about five to six products in the Indian market.

 “Entering Sri Lanka is part of a global expansion strategy… The company has partnered with Sri Lanka’s Ceylon and Foreign Trades PLC,” the Elder Health Care Managing Director, Anuj Saxena, said in a statement.

He said under the partnership, the company will launch oral care, skin care and personal care products along with deodorants, soaps, mouth wash, rose water, face wash and fairness creams under its own brands.
Elder Health Care has oral care, personal care and skin care products under different brands, including Fairone, Tiger and AMPM.
Mr Saxena said the company “is also looking at some acquisitions to enter the European market’’. Apart from Sri Lanka, Elder Health Care also plans to enter Bangladesh, which is another lucrative market.
He, however, did not provide further details on the Bangladesh plans.
On increasing the portfolio of Elder Health Care’s own branded products, Mr Saxena said: “As part of our next five-year roadmap, we plan to build our own brands rather than go for in-licensed products.”
Based on this shift in strategy, the firm aims to have a 50:50 ratio between in-licensed products and owned brands in its portfolio over the next five years against the present 90:10 ratio in favour of in-licensed products.
The Mumbai-based firm is also looking to more than double its revenues in the next two years from Rs 114 crore in FY’11 to Rs 300 crore by FY’13, riding on the back of its expansion plans.

Business: (Latest Stories)